A small study found MS patients reported improved quality of life and reduced depression after Ocrelizumab biosimilar treatment ...

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed. A new artificial intelligence ...

Spurred by her past struggles with dissociative identity disorder, she has devoted her professional life to studying it.

A major Murdoch University review has found that for many people with multiple sclerosis (MS), walking is hindered not only ...

New draft guidance from the FDA on multiple myeloma endpoints reflects the new technology available to assess disease and how patient journeys have changed with better treatments.

ASH 2025 immunotherapy data highlight the importance of treatment sequencing, real-world outcomes in high-risk populations, ...

UCLA Health researchers have created a comprehensive map showing how eight different genetic mutations associated with autism ...

The rapid proliferation of high-efficacy disease-modifying therapies for multiple sclerosis (MS) has revolutionized the treatment landscape, yet significant gaps remain in how health systems organize ...

Multiple Myeloma (MM) research is at the forefront of personalized medicine, driven by rapid advancements in laboratory genomics and molecular diagnostics.

Dendritic cells (DCs) are central players in cancer immunity, serving as the primary link between innate and adaptive immune responses. Their functional ...